Virtual Library

Start Your Search

  • WCLC 2017

    18th World Conference on Lung Cancer

    Access to all presentations that occur during the 18th World Conference on Lung Cancer in Yokohama, Japan

    Presentation Date(s):  
    • Oct 15 - 18, 2017
    • Total Presentations: 2295

    To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.

    Download PDF of the Conference Program: Click Here.
    Onsite Conference Program Addendum (17/10/2017): Click Here.
    Download PDF of the Abstract Book: Click Here.

    Presentations will be available 24 hours after their live presentation time

Filter Results:

Show Only Available Presentations

  • +

    MA 05 - Immuno-Oncology: Novel Biomarker Candidates

    • Type: Mini Oral
    • Track: Immunology and Immunotherapy
    • Presentations: 15
    • Moderators:Yoichi Nakanishi
    • Coordinates: 10/16/2017, 15:45 - 17:30, Room 303 + 304
  • +

    MA 06 - Lung Cancer Biology I

    • Type: Mini Oral
    • Track: Biology/Pathology
    • Presentations: 15
    • Moderators:N. Motoi
    • Coordinates: 10/16/2017, 15:45 - 17:30, Room 501
  • +

    MS 05 - Clinical Issues of Immune Checkpoint Inhibitors

    • Type: Mini Symposium
    • Track: Immunology and Immunotherapy
    • Presentations: 7
    • Moderators:Luis E Raez
    • Coordinates: 10/16/2017, 15:45 - 17:30, Main Hall
  • +

    MS 06 - Combined Modality Treatment for Thymic and Pleural Malignancy

    • Type: Mini Symposium
    • Track: Thymic Malignancies/Esophageal Cancer/Other Thoracic Malignancies
    • Presentations: 7
    • Moderators:Oscar Arrieta
    • Coordinates: 10/16/2017, 15:45 - 17:30, F201 + F202 (Annex Hall)
  • +

    MS 07 - Neuroendocrine Tumors other than SCLC: Pathology to Patient Management

    • Type: Mini Symposium
    • Track: SCLC/Neuroendocrine Tumors
    • Presentations: 7
    • Moderators:C. Barrios
    • Coordinates: 10/16/2017, 15:45 - 17:30, F203 + F204 (Annex Hall)
  • +

    MS 08 - Novel Treatment for Mesothelioma

    • Type: Mini Symposium
    • Track: Mesothelioma
    • Presentations: 8
    • Moderators:Paul Baas
    • Coordinates: 10/16/2017, 15:45 - 17:30, Room 316
  • +

    MS 09 - Global Perspectives in Eliminating the Major Cause of Lung Cancer

    • Type: Mini Symposium
    • Track: Epidemiology/Primary Prevention/Tobacco Control and Cessation
    • Presentations: 7
    • Moderators:Carolyn Dresler
    • Coordinates: 10/16/2017, 15:45 - 17:30, Room 315
  • +

    MS 10 - Evidence Based Care: Interpreting the Research and Enhancing Practice

    • Type: Mini Symposium
    • Track: Nursing/Palliative Care/Ethics
    • Presentations: 6
    • Moderators:Caitlin Broderick
    • Coordinates: 10/16/2017, 15:45 - 17:30, F205 + F206 (Annex Hall)
  • +

    OA 04 - Surgery from Minimal to Radical

    • Type: Oral
    • Track: Surgery
    • Presentations: 9
    • Moderators:J. Lee
    • Coordinates: 10/16/2017, 15:45 - 17:30, Room 311 + 312
  • +

    OA 05 - Next Generation TKI

    • Type: Oral
    • Track: Advanced NSCLC
    • Presentations: 9
    • +

      OA 05.01 - First-Line Dacomitinib versus Gefitinib in Advanced Non-Small-Cell Lung Cancer with EGFR Mutation Subgroups

      15:45 - 15:55  |  Presenter: Yi-Long Wu

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      OA 05.02 - Osimertinib vs SoC EGFR-TKI as First-Line Treatment in Patients with EGFRm Advanced NSCLC (FLAURA): Plasma ctDNA Analysis

      15:55 - 16:05  |  Presenter: Jhanelle Elaine Gray

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      OA 05.03 - Clinical Activity of ASP8273 in Asian Non-Small Cell Lung Cancer Patients with EGFR Activating and T790M Mutations

      16:05 - 16:15  |  Presenter: Keunchil Park

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      OA 05.04 - Discussant - OA 05.01, OA 05.02, OA 05.03

      16:15 - 16:30  |  Presenter: Mark G Kris

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      OA 05.05 - Brigatinib in Crizotinib-Refractory ALK+ NSCLC: Updated Efficacy and Safety Results From ALTA, a Randomized Phase 2 Trial

      16:30 - 16:40  |  Presenter: Myung-Ju Ahn

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      OA 05.06 - Phase 2 Study of Lorlatinib in Patients with Advanced ALK+/ROS1+ Non-Small-Cell Lung Cancer

      16:40 - 16:50  |  Presenter: Ben J Solomon

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      OA 05.07 - Efficacy and Updated Safety of Ceritinib (450 Mg or 600 Mg) with Low-Fat Meal vs 750 Mg Fasted in ALK+ Metastatic NSCLC

      16:50 - 17:00  |  Presenter: Byoung Chul Cho

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      OA 05.08 - Final Result of Phase I/II Study (AF-001JP) of Alectinib, a Selective CNS-Active ALK Inhibitor, in ALK+ NSCLC Patients (Pts)

      17:00 - 17:10  |  Presenter: Makoto Nishio

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      OA 05.09 - Discussant- OA 05.05, OA 05.06, OA 05.07, OA 05.08

      17:10 - 17:25  |  Presenter: Kentaro Tanaka

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.